Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    YS Biopharma Co. Ltd.

    NASDAQ: YS · Real-Time Price · USD
    1.02
    0.09 (9.68%)
    At close: May 24, 2024, 10:00 PM

    YS Biopharma Income Statement

    Financials in CNY. Fiscal year is undefined.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q3 2024 Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023
    Period Ending Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022
    Revenue
    		 619.72M 648.8M 757.46M 581.18M 399.53M 205.48M
    Cost of Revenue
    		 124.9M 133.28M 166.91M 132.23M 93.7M 51.13M
    Gross Profit
    		 494.82M 515.52M 590.55M 448.96M 305.83M 154.34M
    Operating Income
    		 -313.04M -237.26M -136.01M -65.95M -17.84M -11.95M
    Interest Income
    		 14.93M 6.79M 6.79M 6.79M n/a n/a
    Pretax Income
    		 -348.69M -255.05M -168.82M -98.69M -10.56M -18.98M
    Net Income
    		 -305.38M -219.14M -133.75M -64.21M -11.13M -19.59M
    Selling & General & Admin
    		 471.67M 407.68M 389.38M 278.37M 181.87M 96M
    Research & Development
    		 342.6M 330.36M 322.44M 221.8M 123.86M 70.29M
    Other Expenses
    		 -594.92K -951.67K -437.74K -224.74K -224.74K 132K
    Operating Expenses
    		 821.86M 744.02M 730.73M 520.56M 296.1M 166.08M
    Interest Expense
    		 14.93M 22.5M 22.98M 14.95M 14.95M 7.38M
    Selling & Marketing Expenses
    		 303.42M 300.59M 292.58M 213.38M 139.14M 70.49M
    Cost & Expenses
    		 946.76M 877.3M 897.64M 652.79M 389.8M 217.21M
    Income Tax Expense
    		 7.78M 298.65K 1.15M 1.73M 565.63K 612K
    Shares Outstanding (Basic)
    		 93.06M 93.06M 93.06M 92.84M 92.62M 92.17M
    Shares Outstanding (Diluted)
    		 93.06M 93.06M 93.06M 92.84M 92.62M 92.17M
    EPS (Basic)
    		 -3.29 -2.36 -1.44 -0.69 -0.12 -0.21
    EPS (Diluted)
    		 -3.29 -2.36 -1.44 -0.69 -0.12 -0.21
    EBITDA
    		 -280.09M -191.6M -104.73M -35.93M 4.39M -11.61M
    EBIT
    		 -242.08M -182.03M -88.16M -26.06M -26.06M -4.44M
    Depreciation & Amortization
    		 23.9M 14.86M 167.36K 124.08K 163.67K 41.58K

    Add to Watchlist